Replies to post #480474 on NorthWest Biotherapeutics Inc (NWBO)

[HappyLibrarian]

Thankfully NWBO investors have finally learned from the “Crying Wolf!” over the years and are staying well away from any rugs.

The ASCO hype is this blunted and while we are not seeing any big gains before ASCO we are unlikely to see any huge drop when (and if) it’s a nothingburger.

[BTinvesting]

Great post. I agree.

[Red_Right_Hand]

Oh, and this quote attributed to Powerscourt:

“I am looking forward to ASCO next week where Professor Keyoumars Ashkan of Kings College Hospital will be discussing the results of this groundbreaking cancer vaccine study.”

Look at the behavior of NWBO leading up to and following the LL/Mulholland NYAS presentation. Cryptic PRs announcing it, without detail. Slides posted on a 3rd party site instead of NWBOs site. No mention of the sponsor on the slide deck. The company has been completely silent since. All seemingly to avoid running afoul of a journal's embargo. But the LL/Mulholland presentation itself was within a common embargo exception permitting scientists/clinicians to present their research to scientists are a science conference.

But now, the company/sponsor NWBO has booked the Industry Theater, which is peripheral to the ASCO science conference, in the name of the company/sponsor's employee/CTO Bosch, during which "Professor Keyoumars Ashkan of Kings College Hospital will be discussing the results of this groundbreaking cancer vaccine study.”

No way he will be if the embargo is still in place.....